Beyond efficacy: New issues for HSV antiviral therapy

Sexually Transmitted Infections

Volumn 73, Issue 2, 1997, Pages 83-84

  Wald, Anna ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PLACEBO; VALACICLOVIR;

EDITORIAL; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; PRIORITY JOURNAL;

ACYCLOVIR; ANTIVIRAL AGENTS; COHORT STUDIES; HERPES GENITALIS; HUMANS; PATIENT COMPLIANCE; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; VALINE;

EID: 0030988361     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.73.2.83     Document Type: Editorial

References (26)

1. Spruance S, Trying S, Degregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med 1996;156:1729-35. (Pubitemid 26287131)
2. Sacks S, Aoki F, Diaz-Mitoma F, Sellors J, Shafran S. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA 1996;276:44-9.
3. Reichman RC, Badger GH, Mertz GJ, Corey L, Richman DD, Connor JD, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. JAMA 1994;251:2103-7.
4. Nilsen AE, Aasen T, Halsos AM, Kinge BR, Tjotta EAL, Wikstrom K, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982;2:571-3. (Pubitemid 12049485)
5. Goldberg LH, Kaufman R, Conant MA, Sperber J, Allen ML, Illeman M, et al. Oral acyclovir for episodic treatment of recurrent genital herpes. J Am Acad Dermatol 1986;15:256-64. (Pubitemid 16070355)
6. Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al, and the Acyclovir Study Group. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes sirnplex virus infection. JAMA 1991;265:747-51.
7. Goldberg LH, Kaufmnan R, Kurtz TO, Conant MA, Eron LJ, Batenhorst RI, et al, and the Acyclovir Study Group. Long-term suppression of recurrent genital herpes with acyclovir. Arch Dermatol 1993;129:582-7.
8. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS, and the Acyclovir Study Group. Recurrence and resistance patterns of herpes simplex virus following cessation > 6 years chronic suppression with acyclovir. J Infect Dis 1994;169:1338-41. (Pubitemid 24164601)
9. Chulay JD, Bell AR, and the International Valaciclovir HSV Study Group. Long-term safety of valaciclovir for the suppression of herpes simplex virus infections. Clin Infect Dis 1996;23:879.
10. Straus SE, Takiff HE, Seidlin M, Bachrach S, Lininger L, DiGiovanna JJ, et al. Suppression of frequently recurring genital herpes: a placebocontrolled double-blind trial of oral acyclovir. N Engl J Med 1984;310:1545-50. (Pubitemid 14117333)
11. Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984;310:1551-6. (Pubitemid 14117334)
12. Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK, et al. Acyclovir suppression of frequently recurring genital herpes: efficacy and diminishing need during successive years of treatment. JAMA 1988;260:2227-30.
13. Mertz GJ, Loveless MO, Kraus SJ, Tyring SK, Fowler SL, and the Collaborative Famciclovir Genital Herpes Research Group. Famciclovir for suppression of recurrent genital herpes. Abstract. 34th ICAAC, Session 10.
14. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4. (Pubitemid 20316533)
15. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15. (Pubitemid 26019618)
16. Bryson YJ, Dillion M, Lovett M, Acuna G, Taylor S, Cherry JD, et al. Treatiment of first episodes of genital herpes simplex virus infection with oral acyclovir. N Engl J Med 1983;308:916-21.
17. Corey L, Fife KH, Benedetti JK, Winter CA, Fahnlander A, Connor JD, et al. Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med 1983;98:914-21.
18. Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252:1147-51. (Pubitemid 14067513)
19. Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir. Sex Transm Dis 1985;12:215-8. (Pubitemid 16214006)
20. Catotti DN, Clarke P, Catoe KE. Herpes revisited: still a cause of concern. Sex Transm Dis 1993;20:77-80. (Pubitemid 23120833)
21. Luby ED, Klinge V. Genital herpes: a pervasive psychosocial disorder. Arch Dermatol 1985;121:494-7. (Pubitemid 15100841)
22. Carney O, Ross E, Ikkos G, Mindel A. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med 1993;69:457-9.
23. Carney O, Ross E, Bunker C, Ikkos G, Mindel A. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med 1994;70:40-5.
24. Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med 1994;330:738-43. (Pubitemid 24080219)
25. Wild D, Patrick D, Johnson E, Berzon R, Wald A. Measuring the quality of life in persons with genital herpes. Quality of Life Research 1995;4:532-9.
26. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital HSV-2 shedding in immunocompetent women. J Clin Invest 1997;99:1092-7.